STOCK TITAN

PSYCHED WELLNESS LTD - PSYCF STOCK NEWS

Welcome to our dedicated page for PSYCHED WELLNESS news (Ticker: PSYCF), a resource for investors and traders seeking the latest updates and insights on PSYCHED WELLNESS stock.

Psyched Wellness Ltd. (PSYCF) is a life sciences company based in Toronto, Ontario, focused on producing and distributing health and wellness products derived from the Amanita Muscaria mushroom. The company is dedicated to creating premium mushroom-derived products that promote stress relief, relaxation, and restful sleeping. With a proprietary extract (AME-1), Psyched Wellness aims to become a leading brand in the emerging functional food category. The recent initiatives include sponsoring and attending conferences, developing new products like Calm Extract and Amanita Muscaria watermelon Gummies, and expanding their route-to-market partnerships.

Rhea-AI Summary

Psyched Wellness (CSE: PSYC) (OTCQB: PSYCF) announces changes to its board of directors. Harrison Aaron, a nominee of Gotham Green Partners, has resigned effective November 22, 2024. Trevor Mayer, Associate General Counsel at Gotham Green, has been appointed as the replacement nominee director. Mayer, who joined Gotham Green in 2019, brings experience in private equity M&A and fund formation from his previous roles at Kirkland & Ellis LLP and Cooley LLP. He graduated with honors from the University of Chicago Law School and the University of Texas at Austin.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.5%
Tags
management
-
Rhea-AI Summary

Psyched Wellness (CSE: PSYC) (OTCQB: PSYCF) has announced a supply chain disruption at its sole US manufacturing facility on July 27, 2024. The facility, operated by a third-party contractor, produces Psyched's proprietary extracts AME-1 and Calm. In response, the company has suspended online sales to prioritize supporting retail partners and monthly subscribers for the next 8-12 weeks using existing inventory.

CEO Jeffrey Stevens stated that the company is focused on securing additional co-manufacturers to resume production as soon as possible. This disruption highlights the importance of a reliable supply chain for Psyched Wellness's operations and its commitment to maintaining product availability for customers.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.25%
Tags
none
-
Rhea-AI Summary

Psyched Wellness (CSE: PSYC) (OTCQB: PSYCF), a company focused on Amanita Muscaria mushroom products, has expanded its retail partnerships to include Harmons, a Utah-based upscale supermarket chain. Calm, their product, will be available in 16 Harmons locations. To support this, Psyched has engaged UNFI, the largest health and specialty food distributor in North America.

The company has also appointed Kyle Nazareth as Chief Financial Officer, effective July 17, 2024. Nazareth brings over a decade of experience in managing public companies and advising on capital market transactions. He succeeds Keith Li, who served as CFO since January 2020.

Psyched Wellness continues to focus on partnering with specialty retailers offering high-quality products, aiming to differentiate itself as the first legal Amanita Muscaria-derived product for human consumption in the United States.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5%
Tags
management
Rhea-AI Summary

Psyched Wellness, a life sciences company focused on Amanita Muscaria mushroom-derived products, is set to launch Amanita Muscaria watermelon gummies in the U.S. this summer. These gummies, named "Fly (Agaric)", will be the first legal and safe gummies of their kind in the U.S., utilizing the company's proprietary extract, AME-1. The product responds to customer preference for gummies, offering convenience and flavor. Psyched Wellness plans to expand its market reach and anticipates these gummies will outperform their tincture sales. For more information, visit psyched-wellness.com or contact their sales team at sales@psyched-wellness.com.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.64%
Tags
none
-
Rhea-AI Summary

Psyched Wellness announced the grant of 3,800,000 stock options to its directors, officers, consultants, and employees under its Stock Option Plan. These options will vest in four months and the underlying shares are subject to a four-month hold period as per CSE policies. CEO Jeff Stevens expressed the company's commitment to reward its team for securing a $7.5M USD investment from Gotham Green Partners, ensuring alignment with the company's success. The company aims to boost direct-to-consumer (D2C) sales through its online store and expand its presence in brick-and-mortar retailers. Psyched Wellness is the first to offer Amanita Muscaria products in Erewhon, Market of Choice, and Good Earth Markets. Their proprietary extract, AME-1, is the first legal Amanita Muscaria extract for human consumption in the USA, positioning the company for upcoming retail launches.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.39%
Tags
none
-
Rhea-AI Summary
Psyched Wellness Ltd. announces the departure of Chief Commercial Officer Matthew Singh. The company expresses gratitude for his service and wishes him well. For more details, contact CEO Jeffrey Stevens.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.82%
Tags
none
Rhea-AI Summary
Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) is debuting its Calm Extract product at Pop-up Grocer in New York City on December 15th. The company, focused on health and wellness products derived from the Amanita Muscaria mushroom, aims to showcase its transformative benefits to consumers. This partnership with Pop-up Grocer reflects the company's commitment to offering innovative and unique products to a discerning audience.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.71%
Tags
none
-
Rhea-AI Summary
Psyched Wellness Ltd. announces sponsorship and participation at the Wonderland Conference in Miami. They will have a booth to engage with consumers and introduce their product Calm. They offer a 20% discount on conference tickets for their community. Calm is the only Amanita Muscaria product with FDA approval. No concrete business takes affecting stock price.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.33%
Tags
none
-
Rhea-AI Summary
Psyched Wellness expands brick and mortar presence with listing at Market of Choice locations
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.04%
Tags
none
Rhea-AI Summary
Psyched Wellness announces expansion of Calm in Central Market locations, partnering with strategic retailers
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-16.67%
Tags
none

FAQ

What is the current stock price of PSYCHED WELLNESS (PSYCF)?

The current stock price of PSYCHED WELLNESS (PSYCF) is $0.01275 as of December 20, 2024.

What is the market cap of PSYCHED WELLNESS (PSYCF)?

The market cap of PSYCHED WELLNESS (PSYCF) is approximately 4.0M.

What is Psyched Wellness Ltd. focused on?

Psyched Wellness Ltd. is focused on producing and distributing health and wellness products derived from the Amanita Muscaria mushroom.

What are some of the recent achievements of Psyched Wellness Ltd.?

Recent achievements include sponsoring and attending conferences, developing new products like Calm Extract and Amanita Muscaria watermelon Gummies, and expanding route-to-market partnerships.

What are the key objectives of Psyched Wellness Ltd.?

The key objectives include creating premium mushroom-derived products that promote stress relief, relaxation, and assist with restful sleeping.

What is the proprietary extract used by Psyched Wellness Ltd.?

Psyched Wellness uses the proprietary extract AME-1 in their products, making them the first legal and safe Amanita Muscaria products in the USA.

How can I learn more about ordering products from Psyched Wellness Ltd.?

For more information about ordering products, visit the Psyched Wellness website at psyched-wellness.com.

PSYCHED WELLNESS LTD

OTC:PSYCF

PSYCF Rankings

PSYCF Stock Data

4.04M
142.63M
6.83%
43.22%
Packaged Foods
Consumer Defensive
Link
United States of America
Toronto